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tus, study design or language of publication were imple-
mented. Finally, we included 52 publications and remain-
ing 20 were excluded from the study.
Results: Environmental pollution exert their detrimen-
tal effects on heart by developing pulmonary inflamma-
tion, systemic inflammation, enhanced coagulation,
thrombosis, acute arterial vasoconstriction, atherosclero-
sis and coronary artery disease.
Conclusion: Environmental pollution exert detrimental
effects on the heart. The researchers and physicians must
consider the environmental pollution as an emerging fac-
tor in the development of coronary artery disease.
http://dx.doi:10.1016/j.jsha.2016.04.079
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79. Basal-bolus insulin compared to premixed ins-
ulin in cardiac outpatients with type 2 diabetes
A. Enoz
National Guard Health Affairs, Riyadh, Saudi Arabia
Diabetes is a highly prevalent chronic disease world-
wide. It was observed inKing Abdul-Aziz Cardiac Centre
(KACC) that, subjects treated with basal bolus insulin
showed better glycemic control than premixed insulin.
Aim: To compare the efficacy and safety of basal-bolus
insulin, to premixed insulin in subjects with type 2 dia-
betes. Retrospective, comparison, chart review study
included all subjects with type 2 diabetes in KACC fol-
lowed up in the Cardiac Diabetes Clinic, between 2010
and 2015, who are treated with basal bolus insulin or pre-
mixed insulin. Data including HbA1C, body weight, and
hypoglycemia events, pre and 1 year post initiation of
insulin therapy, will be extracted from all subject’s med-
ical records. Results will be compared between the two
groups and analyzed using SPSS. Data for 400 patients
was collected and analyzed. Patients were divided into
two groups, Group (A) who received premixed Insulin
70/30 and Group (B) which included all patients who
received Basal Bolus Insulin (N 170). Group A included
230 patients, 72% of subject in this group were Female
with mean age of 64 years (STD 10), with mean HbA1c
of 9.6% pre insulin use compared to 9.1% one year later
(p 0.001). Group (B) included 170 patients with 64% of
them were male with mean age of 61 (STD 12), with mean
HbA1c of 9.9% before the use of Basal bolus insulin com-
pared to 9.1% one year later (p 0.001). However there was
no significant difference in the effect of Premixed insulin
compared to Basal Bolus insulin on HbA1c. The use of
either Basal Bolus insulin or Premixed has similar signif-
icant effect on HbA1c.
http://dx.doi:10.1016/j.jsha.2016.04.080
80. Heart failure in CVDMP daily practice: Charac-
teristics, management and outcomes
M. Alkhateeb a, R. Odeh b, B. Bdeir c
aNGHA, Riyadh, Saudi Arabia; bKACC, Riyadh, Saudi
Arabia; cNGHA, Riyadh, Saudi Arabia
Background: The characteristics and outcomes of heart
failure (HF) patients have been described by numerous
studies worldwide. However very limited information is
available about Saudi HF patients.
Aim: To determine the general characteristics, treat-
ment, and outcomes of Saudi patients with the diagnosis
of HF followed up in a Nurse-Led Cardiovascular Dis-
ease Management Program (CVDMP) in King Abdulaziz
Cardiac Centre (KACC). This is a retrospective chart
review study, that included all HF who are followed up
in KACC/CVDMP over the time period from 2000 to
2015. Data extracted from the cardiac electronic data base
(Apollo) for all patients who have at least 2 visits; enroll-
ment (EV) and last follow up (LV). A total of 2298 patients
(72% Male, mean age 58 STD 12.7 years) included in this
study. Ischemic cardiomyopathy presented in 60% of
patients, diabetes mellitus in 66%, dyslipidemia in 76%
and 64% of patients were hypertensive. Majority of
patients had both Systolic and Diastolic HF (70%), with
stage C HF in EV and LV. Avarage EF improved from
32% to 38% (P 0.0001). Over 90% of the patients were
on ACE, ARBs or the combination during EV and LV.
Overall mortality was 12.1%. Saudi heart failure patients
are relatively younger with higher prevalence of cardiac
risk factors. These patients are treated as per Guideline
recommended therapy.
http://dx.doi:10.1016/j.jsha.2016.04.081
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